Left Ventricular Diastolic Dysfunction in End‐Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1744-9987|19|5|427-435

ISSN： 1744-9979

Source： THERAPEUTIC APHERESIS AND DIALYSIS, Vol.19, Iss.5, 2015-10, pp. : 427-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 3, 2015-05 ,pp. : 259-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 114, Iss. 1, 2009-10 ,pp. : c74-c80

Karger

Access to resources Recommend Favorite

Diagnosis, Pathogenesis, and Treatment Prospects in Cystic Kidney Disease

By Bergmann Carsten  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 3, 2006-01 ,pp. : 163-174

Adis International

Access to resources Recommend Favorite

Cochrane commentary

By  

NEPHROLOGY, Vol. 20, Iss. 4, 2015-04 ,pp. : 302-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticancer Drugs in End‐Stage Kidney Disease Patients

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 413-416

John Wiley & Sons Inc

Access to resources Recommend Favorite